Emergency Relief Package Includes $80 Million in Funding for the FDA to Fight Coronavirus
The coronavirus emergency relief bill that went into effect in March will include money earmarked for the U.S. Food and Drug Administration (FDA) to help respond to the coronavirus.
The $2 trillion coronavirus aid bill includes $80 million for the FDA to continue its COVID-19 efforts, which include "the development of medical countermeasures and vaccines, promoting the advanced manufacturing of medical products and monitoring of the medical product supply chain," according to a press release from the FDA.
The $80 million is in addition to the $61 million the FDA received from earlier coronavirus legislation bill.
Also involved in the bill is a change in how the FDA regulates over-the-counter (OTC) drugs. The new legislation will help the FDA to modernize its OTC drug development and review process.